DOX-loaded TNPHER2PEP [EG8] with a peptide density of 0.25–0.5% caused 68% reduction in the tumor volume compared to the untargeted formulation in an orthotopic MMTV(Mouse mammary tumor virus)-neu transplantation mouse model without changing the bodyweight of treated mice [115]. This evidence concerns the gene ERBB2 and neoplasm.